National Human Genome Research Institute; Notice of Closed Meetings, 45038-45039 [2017-20698]
Download as PDF
<![CDATA[
asabaliauskas on DSKBBXCHB2PROD with NOTICES
45038
Federal Register / Vol. 82, No. 186 / Wednesday, September 27, 2017 / Notices
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Lawrence Ka-Yun Ng,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6152,
MSC 7804, Bethesda, MD 20892, 301–357–
9318, ngkl@csr.nih.gov.
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group; Radiation Therapeutics and Biology
Study Section.
Date: October 23–24, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Bo Hong, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 6194, MSC 7804, Bethesda, MD
20892, 301–996–6208, hongb@csr.nih.gov.
Name of Committee: Risk, Prevention and
Health Behavior Integrated Review Group;
Addiction Risks and Mechanisms Study
Section.
Date: October 23–24, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Contessa, 306 W Market
Street, San Antonio, TX 78205.
Contact Person: Kristen Prentice, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3112,
MSC 7808, Bethesda, MD 20892, (301) 496–
0726, prenticekj@mail.nih.gov.
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group; Clinical Oncology Study Section.
Date: October 23, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton Reston Hotel, 11810
Sunrise Valley Drive, Reston, VA 20191.
Contact Person: Malaya Chatterjee, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6192,
MSC 7804, Bethesda, MD 20892, 301–806–
2515, chatterm@csr.nih.gov.
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group; Adult Psychopathology and Disorders
of Aging Study Section.
Date: October 23–24, 2017.
Time: 8:30 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Lorien Hotel & Spa, 1600 King
Street, Alexandria, VA 22314.
Contact Person: Serena Chu, Ph.D.,
Scientific Review Officer, BBBP IRG, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3178,
MSC 7848, Bethesda, MD 20892, (301) 500–
5829, sechu@csr.nih.gov.
VerDate Sep<11>2014
18:59 Sep 26, 2017
Jkt 241001
Name of Committee: Infectious Diseases
and Microbiology Integrated Review Group;
Virology—B Study Section.
Date: October 23–24, 2017.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Georgetown Marriott, 1221 22nd St.
NW., Washington, DC 20037.
Contact Person: John C. Pugh, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1206,
MSC 7808, Bethesda, MD 20892, (301) 435–
2398, pughjohn@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Larynx and Voice Disorders.
Date: October 23, 2017.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Unja Hayes, Ph.D.,
Scientific Review Officer, National Institutes
of Health, Center for Scientific Review, 6701
Rockledge Drive, Bethesda, MD 20892, 301–
827–6830, unja.hayes@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Investigations on Primary Immunodeficiency
Diseases.
Date: October 23, 2017.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Jin Huang, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4095G,
MSC 7812, Bethesda, MD 20892, 301–435–
1230, jh377p@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: September 21, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–20629 Filed 9–26–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel; Rare
Diseases SBIR.
Date: October 16, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Marriott Bethesda North, 5701
Marinelli Rd, Rockville, MD 20852
Contact Person: Yin Liu, Ph.D., MD.,
Scientific Review Officer, Scientific Review
Branch, National Institute of Arthritis and
Musculoskeletal and Skin Diseases, National
Institute of Health, 6701 Democracy Blvd.,
Suite 824, Bethesda, MD 20892, 301–594–
4952, liuy@exchange.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: September 21, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–20630 Filed 9–26–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Human
Genome Research Institute Initial Review
Group; Genome Research Review Committee.
E:\FR\FM\27SEN1.SGM
27SEN1
45039
Federal Register / Vol. 82, No. 186 / Wednesday, September 27, 2017 / Notices
Date: November 2–3, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Keith McKenney, Ph.D.,
Scientific Review Officer, National Human
Genome Research Institute Initial Review
Group, 5635 Fishers Lane, Suite 4076, MSC
9306, Bethesda, MD 20814, 301–594–4280,
mckenneyk@mail.nih.gov.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel; DAP (Diversity Action Plan).
Date: November 6, 2017.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute Initial Review Group, 5635 Fishers
Lane, Suite 3146, Rockville, MD (Telephone
Conference Call).
Contact Person: Rudy O. Pozzatti, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Human Genome Research
Institute, 5635 Fishers Lane, Suite 4076, MSC
9306, Rockville, MD 20852, (301) 402–0838,
pozzattr@mail.nih.gov.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel; Advance Sequencing Technology SEP.
Date: November 17, 2017.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute Initial Review Group, 5635 Fishers
Lane, 3rd Floor Conference Room, Rockville,
MD 20852 (Telephone Conference Call).
Contact Person: Ken D. Nakamura, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Human Genome Research
Institute, National Institutes of Health, 5635
Fishers Lane, Suite 4076, MSC 9306,
Rockville, MD 20852, 301–402–0838,
nakamurk@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: September 22, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–20698 Filed 9–26–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
asabaliauskas on DSKBBXCHB2PROD with NOTICES
National Institutes of Health
National Institute of Nursing Research;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
VerDate Sep<11>2014
18:59 Sep 26, 2017
Jkt 241001
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Nursing Research Special Emphasis Panel;
Multicenter Clinical Grants.
Date: October 11, 2017.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, Room 703, 6701
Democracy Boulevard, Bethesda, MD 20892.
Contact Person: Tamizchelvi Thyagarajan,
Ph.D., Scientific Review Officer, National
Institute of Nursing Research, National
Institutes of Health, Bethesda, MD 20892,
(301) 594–0343, tamizchelvi.thyagarajan@
nih.gov.
Name of Committee: National Institute of
Nursing Research Special Emphasis Panel;
Fellowship Training Grants.
Date: October 12, 2017.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, Room 703, 6701
Democracy Boulevard, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Mario Rinaudo, MD,
Scientific Review Officer, Office of Review,
National Inst of Nursing Research, National
Institutes of Health, 6701 Democracy Blvd.
(DEM 1), Suite 710, Bethesda, MD 20892,
301–594–5973, mrinaudo@mail.nih.gov.
Name of Committee: National Institute of
Nursing Research Special Emphasis Panel;
NINR Clinical Trial Planning Grant.
Date: October 16, 2017.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, Room 703, 6701
Democracy Boulevard, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Tamizchelvi Thyagarajan,
Ph.D., Scientific Review Officer, National
Institute of Nursing Research, National
Institutes of Health Bethesda, MD 20892,
(301) 594–0343, tamizchelvi.thyagarajan@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.361, Nursing Research,
National Institutes of Health, HHS)
Dated: September 21, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–20631 Filed 9–26–17; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
Approval of American Cargo
Assurance, Pasadena, TX, as a
Commercial Gauger
U.S. Customs and Border
Protection, Department of Homeland
Security.
ACTION: Notice of approval of American
Cargo Assurance, Pasadena, TX, as a
commercial gauger.
AGENCY:
Notice is hereby given,
pursuant to CBP regulations, that
American Cargo Assurance, Pasadena,
TX, has been approved to gauge
petroleum and petroleum products for
customs purposes for the next three
years as of August 10, 2016.
DATES: As of August 10, 2016, American
Cargo Assurance, Pasadena, TX, was
reapproved as a Customs-approved
commercial gauger. The next triennial
inspection date will be scheduled for
August 2019.
FOR FURTHER INFORMATION CONTACT: Mr.
Stephen Cassata, Laboratories and
Scientific Services, U.S. Customs and
Border Protection, 1300 Pennsylvania
Avenue NW., Suite 1500N, Washington,
DC 20229, tel. 202–344–1060.
SUPPLEMENTARY INFORMATION: Notice is
hereby given pursuant to 19 CFR 151.13,
that American Cargo Assurance, 1404
South Houston Rd., Suite B, Pasadena,
TX 77502, has been approved to gauge
petroleum and petroleum products in
accordance with the provisions of 19
CFR 151.13. American Cargo Assurance,
is approved for the following gauging
procedures for petroleum and certain
petroleum products set forth by the
American Petroleum Institute (API):
SUMMARY:
API chapters
3 .....................
7 .....................
8 .....................
12 ...................
Title
Gauging.
Temperature Determination.
Sampling.
Calculation of Petroleum
Quantities.
Anyone wishing to employ this entity
to conduct gauger services should
request and receive written assurances
from the entity that it is approved by the
U.S. Customs and Border Protection to
conduct the specific gauger service
requested. Alternatively, inquiries
regarding the specific gauger service this
entity is approved to perform may be
directed to the U.S. Customs and Border
Protection by calling (202) 344–1060.
The inquiry may also be sent to
cbp.labhq@dhs.gov. Please reference the
Web site listed below for a complete
E:\FR\FM\27SEN1.SGM
27SEN1
]]>Agencies
[Federal Register Volume 82, Number 186 (Wednesday, September 27, 2017)]
[Notices]
[Pages 45038-45039]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-20698]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Human Genome Research Institute; Notice of Closed
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Human Genome Research Institute
Initial Review Group; Genome Research Review Committee.
[[Page 45039]]
Date: November 2-3, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, Bethesda, MD 20852.
Contact Person: Keith McKenney, Ph.D., Scientific Review
Officer, National Human Genome Research Institute Initial Review
Group, 5635 Fishers Lane, Suite 4076, MSC 9306, Bethesda, MD 20814,
301-594-4280, mckenneyk@mail.nih.gov.
Name of Committee: National Human Genome Research Institute
Special Emphasis Panel; DAP (Diversity Action Plan).
Date: November 6, 2017.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Human Genome Research Institute Initial Review
Group, 5635 Fishers Lane, Suite 3146, Rockville, MD (Telephone
Conference Call).
Contact Person: Rudy O. Pozzatti, Ph.D., Scientific Review
Officer, Scientific Review Branch, National Human Genome Research
Institute, 5635 Fishers Lane, Suite 4076, MSC 9306, Rockville, MD
20852, (301) 402-0838, pozzattr@mail.nih.gov.
Name of Committee: National Human Genome Research Institute
Special Emphasis Panel; Advance Sequencing Technology SEP.
Date: November 17, 2017.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Human Genome Research Institute Initial Review
Group, 5635 Fishers Lane, 3rd Floor Conference Room, Rockville, MD
20852 (Telephone Conference Call).
Contact Person: Ken D. Nakamura, Ph.D., Scientific Review
Officer, Scientific Review Branch, National Human Genome Research
Institute, National Institutes of Health, 5635 Fishers Lane, Suite
4076, MSC 9306, Rockville, MD 20852, 301-402-0838,
nakamurk@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human
Genome Research, National Institutes of Health, HHS)
Dated: September 22, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-20698 Filed 9-26-17; 8:45 am]
BILLING CODE 4140-01-P
